Search

Author/Creator Meisel, Alexander

1. Neutropenia, neutrophilia, and neutrophil–lymphocyte ratio as prognostic markers in patients with metastatic castration-resistant prostate cancer. (May 2022)

Authors:
Meisel, Alexander; de Wit, Ronald; Oudard, Stephane; Sartor, Oliver; Stenner-Liewen, Frank; Shun, Zhenming; Foster, Meredith; Ozatilgan, Ayse; Eisenberger, Mario; de Bono, Johann S.
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 14(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Severe neutropenia during cabazitaxel treatment is associated with survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TROPIC phase III trial. (March 2016)

Authors:
Meisel, Alexander; von Felten, Stefanie; Vogt, Deborah R.; Liewen, Heike; de Wit, Ronald; de Bono, Johann; Sartor, Oliver; Stenner-Liewen, Frank
Journal:
European journal of cancer
Issue:
Volume 56(2016)
Page Start:
93
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Severe neutropenia during cabazitaxel treatment is associated with survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TROPIC phase III trial. (March 2016)

Authors:
Meisel, Alexander; von Felten, Stefanie; Vogt, Deborah R.; Liewen, Heike; de Wit, Ronald; de Bono, Johann; Sartor, Oliver; Stenner-Liewen, Frank
Journal:
European journal of cancer
Issue:
Volume 56(2016)
Page Start:
93
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗